Etoricoxib Tablet belongs to the selective cyclooxygenase-2 non-steroidal anti-inflammatory drugs, with antipyretic and analgesic anti-inflammatory effects, clinically used in acute and chronic osteoarthritis, acute gouty arthritis, primary dysmenorrhea and so on. Adverse reactions of this product include impaired cardiac function, vascular abnormalities, infections, gastrointestinal function abnormalities, skeletal muscle connective tissue abnormalities, cough, dyspnea and so on. Note that this product is contraindicated in patients with active peptic ulcers or bleeding, patients with a history of recurrent gastrointestinal ulcer bleeding, patients with a history of aspirin asthma, patients with congestive heart failure, patients with ischemic heart disease. Special populations: This product is avoided in women in late pregnancy; nursing women should stop breastfeeding if they need to use the drug; the safety of the drug in children is not clear. Patients should use the drug under the guidance of a professional physician and strictly follow the doctor’s instructions.